Cargando…

MicroRNA‐143/Musashi‐2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer

It has been well established that microRNA (miR)‐143 is downregulated in human bladder cancer (BC). Recent precision medicine has shown that mutations in BC are frequently observed in FGFR3, RAS and PIK3CA genes, all of which correlate with RAS signaling networks. We have previously shown that miR‐1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsujino, Takuya, Sugito, Nobuhiko, Taniguchi, Kohei, Honda, Ryo, Komura, Kazumasa, Yoshikawa, Yuki, Takai, Tomoaki, Minami, Koichiro, Kuranaga, Yuki, Shinohara, Haruka, Tokumaru, Yoshihisa, Heishima, Kazuki, Inamoto, Teruo, Azuma, Haruhito, Akao, Yukihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609826/ https://www.ncbi.nlm.nih.gov/pubmed/31066120 http://dx.doi.org/10.1111/cas.14035

Ejemplares similares

Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS Networks of Renal Cell Cancer Cells In Vitro and In Vivo
por: Takai, Tomoaki, et al.
Publicado: (2019)

Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase
por: Tokumaru, Yoshihisa, et al.
Publicado: (2019)

Impairment of K‐Ras signaling networks and increased efficacy of epidermal growth factor receptor inhibitors by a novel synthetic miR‐143
por: Akao, Yukihiro, et al.
Publicado: (2018)

A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells
por: Takai, Tomoaki, et al.
Publicado: (2017)

Chemically modified MIR143-3p exhibited anti-cancer effects by impairing the KRAS network in colorectal cancer cells
por: Sugito, Nobuhiko, et al.
Publicado: (2022)

SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells
por: Kuranaga, Yuki, et al.
Publicado: (2018)

Anti-cancer Effects of a Chemically Modified miR-143 on Bladder Cancer by Either Systemic or Intravesical Treatment
por: Yoshikawa, Yuki, et al.
Publicado: (2019)

MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells
por: Minami, Koichiro, et al.
Publicado: (2017)

Potent antiproliferative effect of fatty‐acid derivative AIC‐47 on leukemic mice harboring BCR‐ABL mutation
por: Shinohara, Haruka, et al.
Publicado: (2019)

Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression
por: Taniguchi, Kohei, et al.
Publicado: (2018)

Synthetic MIR143-3p Suppresses Cell Growth in Rhabdomyosarcoma Cells by Interrupting RAS Pathways Including PAX3–FOXO1
por: Sugito, Nobuhiko, et al.
Publicado: (2020)

CRISPR Screen Contributes to Novel Target Discovery in Prostate Cancer
por: Tsujino, Takuya, et al.
Publicado: (2021)

Rapid Increase of the Serum PSA Level in Response to High-Intensity Focused Ultrasound Therapy may be a Potential Indicator of Biochemical Recurrence of Low- and Intermediate-Risk Prostate Cancer
por: Inamoto, Teruo, et al.
Publicado: (2011)

Post-operative urothelial recurrence in patients with upper urinary tract urothelial carcinoma managed by radical nephroureterectomy with an ipsilateral bladder cuff: Minimal prognostic impact in comparison with non-urothelial recurrence and other clinical indicators
por: TAKAHARA, KIYOSHI, et al.
Publicado: (2013)

The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma
por: Inamoto, Teruo, et al.
Publicado: (2017)

High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

Petasin potently inhibits mitochondrial complex I–based metabolism that supports tumor growth and metastasis
por: Heishima, Kazuki, et al.
Publicado: (2021)

Effects of MIR143 on rat sarcoma signaling networks in solid tumors: A brief overview
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder
por: Inamoto, Teruo, et al.
Publicado: (2018)

Colorectal cancer cell-derived extracellular vesicles induce phenotypic alteration of T cells into tumor-growth supporting cells with transforming growth factor-β1-mediated suppression
por: Yamada, Nami, et al.
Publicado: (2016)

Targeting microRNA-145-mediated progressive phenotypes of early bladder cancer in a molecularly defined in vivo model
por: Heishima, Kazuki, et al.
Publicado: (2023)

Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft
por: Inamoto, Teruo, et al.
Publicado: (2015)

MicroRNA-214 and MicroRNA-126 Are Potential Biomarkers for Malignant Endothelial Proliferative Diseases
por: Heishima, Kazuki, et al.
Publicado: (2015)

Anti-Oncogenic gem-Dihydroperoxides Induce Apoptosis in Cancer Cells by Trapping Reactive Oxygen Species
por: Kuranaga, Yuki, et al.
Publicado: (2016)

Tumor Tissue MIR92a and Plasma MIRs21 and 29a as Predictive Biomarkers Associated with Clinicopathological Features and Surgical Resection in a Prospective Study on Colorectal Cancer Patients
por: Fukada, Masahiro, et al.
Publicado: (2020)

Postoperative changes in plasma miR21‐5p as a novel biomarker for colorectal cancer recurrence: A prospective study
por: Fukada, Masahiro, et al.
Publicado: (2021)

A Novel Role of Dickkopf-Related Protein 3 in Macropinocytosis in Human Bladder Cancer T24 Cells
por: Tsujimura, Nonoka, et al.
Publicado: (2016)

DEAD-Box Protein RNA-Helicase DDX6 Regulates the Expression of HER2 and FGFR2 at the Post-Transcriptional Step in Gastric Cancer Cells
por: Tajirika, Toshihiro, et al.
Publicado: (2018)

MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis
por: Heishima, Kazuki, et al.
Publicado: (2015)

Immunotherapy of Genitourinary Malignancies
por: Inamoto, Teruo, et al.
Publicado: (2012)

Editorial Comment to Case of renal mucinous tubular and spindle cell carcinoma with high nuclear grade
por: Inamoto, Teruo, et al.
Publicado: (2019)

Editorial Comment to Prostate carcinoma with neuroendocrine differentiation successfully treated by early detection with imaging examination
por: Inamoto, Teruo, et al.
Publicado: (2020)

Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma
por: Miyake, Makito, et al.
Publicado: (2019)

A case of congenital single testis with testicular cancer patient and azoospermia who was able to collect spermatozoa with ipsilateral Onco‐TESE
por: Hayashi, Kazumasa, et al.
Publicado: (2020)

The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma
por: Tsujino, Takuya, et al.
Publicado: (2017)

Understanding of cell death induced by the constituents of Taxus yunnanensis wood
por: Akao, Yukihiro, et al.
Publicado: (2022)

Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~
por: Tsutsumi, Takeshi, et al.
Publicado: (2021)

Remarkable response to fluorouracil, leucovorin, oxaliplatin, and irinotecan therapy in urothelial cancer of the renal pelvis: a case report
por: Tsujino, Takuya, et al.
Publicado: (2017)

Risk stratification by means of biological age-related factors better predicts cancer-specific survival than chronological age in patients with upper tract urothelial carcinoma: a multi-institutional database study
por: Inamoto, Teruo, et al.
Publicado: (2018)

Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort
por: Komura, Kazumasa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k5p6c1mgpogvrv2qnigro2d1fa